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Dear Editor,
A 68-year-old man presented with cervical lymphade-
nopathy and bilateral tonsillar enlargement and ulcer-
ations. Computed tomography (CT) showed an
infiltrative disease (Fig. 1a, arrow). A blood count
showed haemoglobin, 13.1 g/dL; leucocytes, 41.9×109/
L (89 % blasts); and platelets, 48×109/L. Bone marrow
examination confirmed acute myeloid leukaemia (AML)
without maturation (Fig. 1b). Cytogenetic analysis
showed 46,XY,t(7;14)(p13;q32), the significance of
which was unknown. NPM1 and FLT3 genes were wild
type. Unexpectedly, a biopsy of the tonsillar mass
showed infiltration by medium-sized atypical cells with
indistinct cytoplasmic borders (Fig. 1c) and irregular and
grooved nuclei (insert). These atypical cells were posi-
tive for CD1a (Fig. 1d) and S100 (Fig. 1e). Myeloblasts
were not evident. Pathological features were consistent
with Langerhans cell histiocytosis (LCH). Marrow tre-
phine biopsy showed myeloblasts intermixed with nu-
merous atypical cells (Fig. 1f), which were also S100
positive (Fig. 1g). The overall diagnosis was therefore
consistent with concomitant disseminated LCH and
AML. As leukaemia treatment was more urgent, a stan-
dard AML regimen of daunorubicin (60 mg/m2/day×
3 days) and cytarabine (100 mg/m2/day×7 days) was
administered. Interestingly, the tonsillar masses and cer-
vical lymphadenopathy subsided, and a day-22 marrow
examination showed complete remission of AML and
LCH. A positron emission tomography/CT (PET/CT)
also confirmed complete response of the LCH. Two
consolidation courses of high-dose cytarabine have since
been given, with the patient remaining in CR 6 months
after diagnosis.
LCH in association with leukaemia occurs mainly in
two clinical patterns: LCH preceded by acute lympho-
blastic leukaemia (pathogenesis undefined) and LCH
treated by etoposide/vinblastine followed by therapy-
related AML [1]. Concomitant LCH and AML have
very rarely been reported [2,3]. Two explanations for
this extraordinary phenomenon have been proposed:
LCH and AML deriving from the same neoplastic pre-
cursors or LCH being reactive to the AML [1–3]. In our
patient, the LCH was infiltrative with marrow metasta-
sis, supporting that it was neoplastic. In addition to its
diagnostic interest, this case had therapeutic implication.
The optimal treatment of disseminated LCH remains
undefined. The use of vinblastine, etoposide, 2-
chlorodeoxyadenosine, cyclophosphamide and cytarabine
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has been described [4]. Anthracyclines have apparently
not been studied before. Our case showed fortuitously
that a standard daunorubicin/cytarabine regimen was
highly effective in inducing a remission for disseminat-
ed LCH, an observation that requires further validation.
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Fig. 1 Concomitant disseminated Langerhans cell histiocytosis and
acute myeloid leukaemia. a Computed tomography showing bilaterally
enlarged tonsils, more prominent on the left side (arrow). b Marrow
aspirate showing predominance of myeloblasts. c Tonsillar biopsy,
showing infiltration by a population of atypical cells with indistinct
cytoplasmic borders. High-power view (insert) showed atypical cells
with nuclei containing linear grooves. d The tonsillar atypical cells
were positive for CD1a (immunoperoxidase). e The tonsillar atypical
cells were positive for S100. f Trephine biopsy of the marrow, showing
admixture of myeloblasts and atypical cells with elongated and
grooved nuclei. g Atypical cells in the marrow were positive for S100
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